WHO ICTRP trial
Ensayo clínico para evaluar la eficacia y seguridad de la rapamicina en los…
EUCTR2007-005978-30-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-005978-30-ES |
|---|---|
| Public title | Ensayo clínico para evaluar la eficacia y seguridad de la rapamicina en los angiomiolipomas en pacientes con esclerosis tuberosa Clinical Trial to Determine the Efficacy and Safety of Rapamycin in Angiomyolipomas in Pacients with Tuberous Sclerosis |
| Scientific title | Ensayo clínico para evaluar la eficacia y seguridad de la rapamicina en los angiomiolipomas en pacientes con esclerosis tuberosa Clinical Trial to Determine the Efficacy and Safety of Rapamycin in Angiomyolipomas in Pacients with Tuberous Sclerosis |
| Primary sponsor | FUNDACIÓ PUIGVERT |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Angiomiolipomas en pacientes con esclerosis tuberosa (angiomyolipoma of tuberous sclerosis patients) MedDRA version: 9.1 Level: LLT Classification code 10045138 Term: Tuberous sclerosis |
| Interventions | Trade Name: Rapamune Product Name: Rapamune Pharmaceutical Form: Oral solution INN or Proposed INN: sirolimus Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 1- Trade Name: Rapamune Product… |
| Registration date | Mar 12, 2007 |
| Secondary IDs | FP2007/02 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: